iPSC-Derived Macrophages Effectively Treat Pulmonary Alveolar Proteinosis in Csf2rb-Deficient Mice

[1]  B. Trapnell,et al.  Pulmonary Transplantation of Human Induced Pluripotent Stem Cell‐derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis , 2018, American journal of respiratory and critical care medicine.

[2]  F. Ginhoux,et al.  Induced‐Pluripotent‐Stem‐Cell‐Derived Primitive Macrophages Provide a Platform for Modeling Tissue‐Resident Macrophage Differentiation and Function , 2017, Immunity.

[3]  A. Engelman,et al.  Haematopoietic stem and progenitor cells from human pluripotent stem cells , 2017, Nature.

[4]  M. D. Moore,et al.  Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages , 2017, Stem cell reports.

[5]  A. Schambach,et al.  Murine iPSC-Derived Macrophages as a Tool for Disease Modeling of Hereditary Pulmonary Alveolar Proteinosis due to Csf2rb Deficiency , 2016, Stem cell reports.

[6]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[7]  C. Ackerley,et al.  Alveolar-like Stem Cell-derived Myb(-) Macrophages Promote Recovery and Survival in Airway Disease. , 2016, American journal of respiratory and critical care medicine.

[8]  E. Paredes-Gamero,et al.  Impaired Hematopoiesis and Disrupted Monocyte/Macrophage Homeostasis in Mucopolysaccharidosis Type I Mice , 2016, Journal of cellular physiology.

[9]  N. Hacohen,et al.  Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells , 2016, Science.

[10]  Luigi Naldini,et al.  Gene therapy returns to centre stage , 2015, Nature.

[11]  C. Recordati,et al.  Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts , 2015, Stem cell reports.

[12]  De-Pei Liu,et al.  Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs , 2015, Scientific Reports.

[13]  E. Sidransky,et al.  Gaucher Disease‐Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis , 2015, Stem cells translational medicine.

[14]  F. Ginhoux,et al.  C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. , 2015, Immunity.

[15]  Gesine Hansen,et al.  Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement Therapies , 2015, Stem cell reports.

[16]  Gérard Eberl,et al.  Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection. , 2015, Immunity.

[17]  F. Geissmann,et al.  Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors , 2014, Nature.

[18]  I. Amit,et al.  Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment , 2014, Cell.

[19]  B. Trapnell,et al.  Pulmonary Macrophage Transplantation Therapy , 2014, Nature.

[20]  C. Bain,et al.  The monocyte-macrophage axis in the intestine , 2014, Cellular immunology.

[21]  J. Tisdale,et al.  Wild-type macrophages reverse disease in heme oxygenase 1-deficient mice. , 2014, Blood.

[22]  Adan Chari Jirmo,et al.  Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis , 2014, Science Translational Medicine.

[23]  F. Rossi,et al.  The role of microglia in human disease: therapeutic tool or target? , 2014, Acta Neuropathologica.

[24]  G. Randolph,et al.  Origin and functions of tissue macrophages. , 2014, Immunity.

[25]  D. Steinemann,et al.  Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  A. Schambach,et al.  Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy. , 2014, Biomaterials.

[27]  T. Hussell,et al.  Alveolar macrophages: plasticity in a tissue-specific context , 2014, Nature Reviews Immunology.

[28]  D. Steinemann,et al.  Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis. , 2013, American journal of respiratory and critical care medicine.

[29]  B. Trapnell,et al.  Use of induced pluripotent stem cells to recapitulate pulmonary alveolar proteinosis pathogenesis. , 2013, American journal of respiratory and critical care medicine.

[30]  Bernard Malissen,et al.  Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF , 2013, The Journal of experimental medicine.

[31]  B. van Wilgenburg,et al.  Efficient, Long Term Production of Monocyte-Derived Macrophages from Human Pluripotent Stem Cells under Partly-Defined and Fully-Defined Conditions , 2013, PloS one.

[32]  H. Nakauchi,et al.  Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  I. Nookaew,et al.  Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods , 2013, Nucleic acids research.

[34]  M. Ritchie,et al.  Faculty Opinions recommendation of Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. , 2012 .

[35]  M. Araúzo-Bravo,et al.  Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells. , 2012, Stem cells and development.

[36]  E R Weibel,et al.  A simple tool for stereological assessment of digital images: the STEPanizer , 2011, Journal of microscopy.

[37]  A. Biffi,et al.  Gene therapy for leukodystrophies. , 2011, Human molecular genetics.

[38]  C. Couture,et al.  Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations , 2011, European Respiratory Journal.

[39]  T. Nagayasu,et al.  Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB , 2010, Journal of Medical Genetics.

[40]  Cole Trapnell,et al.  Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.

[41]  S. Cheung,et al.  Brief Definitive Report , 2022 .

[42]  U. Dirksen,et al.  Gene Therapy of βc-Deficient Pulmonary Alveolar Proteinosis (βc-PAP): Studies in a Murine in vivo Model. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[43]  U. Dirksen,et al.  Gene therapy of beta(c)-deficient pulmonary alveolar proteinosis (beta(c)-PAP): studies in a murine in vivo model. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[45]  R. Nishinakamura,et al.  Mice deficient for the IL-3/GM-CSF/IL-5 βc receptor exhibit lung pathology and impaired immune response, while βIL3 receptor-deficient mice are normal , 1995 .

[46]  K. Arai,et al.  Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. , 1995, Immunity.

[47]  G. A. Martin,et al.  cDNA cloning and expression of murine macrophage colony-stimulating factor from L929 cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.